Tianjin Medical University, No.22 Qi xiang tai Road, Heping District, Tianjin, 300070, People's Republic of China.
Department of Cardiology, Tianjin Chest Hospital, No. 261 Tai er zhuang Road, Jinnan District, Tianjin, 300222, People's Republic of China.
J Thromb Thrombolysis. 2021 Apr;51(3):682-692. doi: 10.1007/s11239-020-02184-7.
Whether the clinical outcomes of stent thrombosis (ST) are different when stratified by time of occurrence remains unclear. The objective of this study was to compare the short- and long-term clinical outcomes after percutaneous coronary intervention (PCI) for early stent thrombosis (EST) versus late stent thrombosis (LST) and very late stent thrombosis (VLST). We enrolled eligible studies searched from the main electronic databases (EMBASE, PubMed, Cochrane). The primary endpoints were in-hospital, 30-day, 1-year and long-term mortality. The secondary endpoints included recurrent stent thrombosis (RST) and target vessel/lesion revascularization (TVR/TLR) during hospitalization, at 30 days, at 1 year and at long-term follow-up. A total of 23 studies with 17,592 patients were included. Compared with mortality rates of the late and very late thrombosis (LST/VLST) group, in-hospital (P = 0.004), 30-day (P < 0.00001), 1-year (P < 0.00001) and long-term mortality rates (P = 0.04) were significantly higher in the EST group. The in-hospital TVR/TLR rates were similar between the EST group and the LST/VLST group. However, a higher trend in TVR/TLR rate at 30 days and a significantly higher TVR/TLR rate at 1 year (P = 0.002) as well as at long-term follow up (P = 0.009) were found in the EST group. EST patients also trended toward higher risk of RST in both short- and long-term follow-up than LST/VLST patients, although differences were not statistically significant. After PCI treatment, patients with EST have worse clinical outcomes in both short- and long-term follow-up than patients with LST/VLST. Further studies are warranted to determine the optimal treatment strategies for EST.
发生时间分层后,支架血栓形成(ST)的临床结局是否不同尚不清楚。本研究旨在比较经皮冠状动脉介入治疗(PCI)后早期支架血栓形成(EST)与晚期支架血栓形成(LST)和极晚期支架血栓形成(VLST)的短期和长期临床结局。我们纳入了从主要电子数据库(EMBASE、PubMed、Cochrane)中检索到的合格研究。主要终点是住院期间、30 天、1 年和长期死亡率。次要终点包括住院期间、30 天、1 年和长期随访期间的复发性支架血栓形成(RST)和靶血管/病变血运重建(TVR/TLR)。共纳入 23 项研究,共纳入 17592 例患者。与晚期和极晚期血栓形成(LST/VLST)组的死亡率相比,EST 组住院期间(P=0.004)、30 天(P<0.00001)、1 年(P<0.00001)和长期死亡率(P=0.04)显著升高。EST 组与 LST/VLST 组住院期间 TVR/TLR 发生率相似。然而,EST 组在 30 天 TVR/TLR 发生率呈升高趋势,在 1 年(P=0.002)和长期随访(P=0.009)时 TVR/TLR 发生率显著升高。在短期和长期随访中,EST 患者的 RST 风险也呈升高趋势,尽管差异无统计学意义。PCI 治疗后,EST 患者的短期和长期临床结局均较 LST/VLST 患者差。需要进一步研究以确定 EST 的最佳治疗策略。